NCT03209336 Study of Intraoperative Radiotherapy for Middle and Low Rectal Cancer Status UNKNOWN Phase NA
NCT03204201 Validation of ICG to Identify the Urethra During Rectal Surgery Status TERMINATED Phase PHASE1/PHASE2
NCT03190941 Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Status RECRUITING Phase PHASE1/PHASE2
NCT03171298 Laparoscopic Assisted Transanal Resection of Rectal Cancer With Total Mesorectal Excision Status UNKNOWN Phase NA
NCT03161574 FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer Status WITHDRAWN Phase PHASE2
NCT03151759 MMP-7 Modulation by Short and Long Term Radiotherapy in Rectal Cancer Patients Status COMPLETED Phase N/A
NCT03144765 Multicenter Phase II Study of Transanal TME (taTME) Status ACTIVE_NOT_RECRUITING Phase NA
NCT03120104 Physical Exercise for Colorectal Cancer Patients After Transanal Total Mesorectal Excision Status UNKNOWN Phase NA
NCT03107650 Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer Status COMPLETED Phase N/A
NCT03102047 Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer Status COMPLETED Phase PHASE2
NCT03085992 Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer Status COMPLETED Phase PHASE2
NCT03074461 Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial Status UNKNOWN Phase NA
NCT03068403 Dynamic Contrast Enhanced Ultrasound for Predict and Assess Rectal Cancer Response After Neo-adjuvant Chemoradiation - RECT Status COMPLETED Phase NA
NCT03043729 mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer Status COMPLETED Phase PHASE2
NCT03038256 Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial Status UNKNOWN Phase PHASE2
NCT03015168 Prognostic Value of Neutrophil-to-lymphocyte Ratio (NLR) on Rectal Cancer Patients Status COMPLETED Phase N/A